News and Events
UCLA Urology in the News
The UCLA Department of Urology provides cutting-edge diagnosis and treatments and supports a staff of renowned physicians, surgeons, and researchers. Demonstrating continued excellence in the field of Urology, the UCLA Department of Urology along with its varied Centers of Excellence, is often the subject of stories in newspapers, magazines, and journals. The Department also frequently issues news releases to keep the community informed on the latest developments in urology, the treatments available at UCLA, and various milestones within the Department. We include here a collection of recent stories, and an archive of older articles, for your further information.
July 1, 2026
Should lowest-risk prostate ‘cancer’ still be called cancer? Study suggests changing the name could save lives - Dr. Scott Eggener, chair of the department of urology at the David Geffen School of Medicine at UCLA and senior author of the study, discusses how changing the terminology for Grade Group 1 prostate cancer may reduce overtreatment while encouraging more appropriate screening. Learn more at the UCLA Health Newsroom.
Additional coverage: UCLA Newsroom, KNX (LA), CBS-AM (San Francisco) and WWJ-AM (Detroit), U.S. News & World Report, MedPage Today.
June 23, 2026
UCLA Health study documents successful one-year outcome following first-ever bladder transplant - Dr. Nima Nassiri, urologic transplant surgeon, leads the groundbreaking UCLA Health clinical trial that launched by transferring a kidney and a bladder into a 41-year-old cancer survivor in May 2025. Learn more at the UCLA Health Newsroom.
June 23, 2026
How a UCLA Health transplant surgeon made medical history - Dr. Nima Nassiri, urologic transplant surgeon, spent years doing practice runs, often in the middle of the night, to pull off a bladder transplant no one had successfully done before. Learn more at the UCLA Health Newsroom.
June 23, 2026
Treating recurrent UTIs in older women - Dr. Anne Ackerman, assistant professor of urology at the David Geffen School of Medicine at UCLA, provides expert commentary to Medscape.
June 11, 2026
UCLA physicians recognized for their achievements in urology - Drs. Robert Reiter and Nima Nassiri have been named recipients of the 2026 Research Awards of Distinction by the Urology Care Foundation and the American Urological Association. Learn more at the UCLA Newsroom.
June 10, 2026
Why new dads shouldn’t panic about low testosterone - Dr. Jesse Mills, professor of urology at the David Geffen School of Medicine at UCLA, provides expert commentary to the Los Angeles Time.
June 9, 2026
The Ancient Root Guys Are Suddenly Using to Boost Their T - Dr. Rajiv Jayadevan, assistant clinical professor of urology and male fertility expert at The Men’s Clinic at UCLA, provides expert commentary to Men's Health.
May 20, 2026
Is it bad to use a laptop right on your lap? - Dr. Jesse Mills, professor of urology at the David Geffen School of Medicine at UCLA, provides expert commentary to TIME Magazine.
May 14, 2026
UCLA researchers and surgeons will present on key developments in urologic health at the annual American Urological Association meeting - Dr. Wayne Brisbane, Dr. Sriram Eleswarapu, Dr. Mary Fakunle, Dr. Nima Nassiri, and Dr. Jesse Mills presented ath the annual AUA meeting. Learn more at the UCLA Health Newsroom.
April 24, 2026
Jonathan Bergman named a 2026 Young Urologist of the Year - Dr. Jonathan Bergman, professor of urology and family medicine at the David Geffen School of Medicine at UCLA, has been named a 2026 Young Urologist of the Year by the American Urological Association (AUA). Learn more at the UCLA Newsroom.
March 24, 2026
Airtalk with Larry Mantle/KPCC-FM - Dr. Jesse Mills, director of the men's clinic at UCLA, fellowship director of the UCLA male reproductive medicine and surgery program, and director of UCLA Urology Santa Monica, provides expert commentary to LAist.
March 19, 2026
Scientists “turbocharge” immune cells to attack prostate cancer - Dr. Tanya Stoyanova, professor of urology and molecular and medical pharmacology at the David Geffen School of Medicine at UCLA,, is apart of the research team that is working towards safer, more effective T cell therapies for prostate cancer and other solid tumors. Learn more at the UCLA Health Newsroom.
March 17, 2026
Breedlife Foundation Fundraiser and kidney donations - Dr. Jeffrey Veale, kidney transplant surgeon and director of the UCLA Kidney Transplantation Exchange Program at UCLA Health, interviews with CBS Los Angeles.
March 2, 2026
‘Potentially Practice-Changing’: Targeted Therapy Shown To Improve Survival For Men With Certain Subtype of Advanced Prostate Cancer - Dr. Alexandra Drakaki, associate professor of Hematology/Oncology and Urology and a member of the UCLA Health Jonsson Comprehensive Cancer Center, provides expert commentary to Survivor Net.
March 2026
Rewriting the future - Dr. Jeffrey Veale, professor of urology at the David Geffen School of Medicine at UCLA, discusses UCLA Health’s retroactive tolerance protocol. Learn more at the UCLA Health Newsroom.
February 26, 2026
Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, UCLA study finds - Dr. Wayne Brisbane, Dr. Scott Eggener, Dr. Robert Reiter and Dr. Matthew Rettig from UCLA Urology, are authors on a study that's findings could help patients avoid side significant effects and improve quality of life. Learn more at the UCLA Health Newsroom.
February 17, 2026
They paved the way for countless kidney transplantations. Next stop? Immune tolerance - Dr. Jeffrey Veale, professor of urology at the David Geffen School of Medicine at UCLA, discusses new ideas to improve immune tolerance by revolutionizing the field of transplant medicine. Learn more at the UCLA Health Newsroom.
February 16, 2026
Docetaxel rechallenge a ‘better choice’ than cabazitaxel for metastatic prostate cancer - Dr. Matthew Rettig, medical director of the Prostate Cancer Program of the Institute of Urologic Oncology at UCLA and a member of the UCLA Health Jonsson Comprehensive Cancer Center, provides expert commentary to Healio.
February 11, 2026
Time names the 100 'Most Influential People in Health' - Dr. Nima Nassiri, assistant clinical professor of urology at the UCLA David Geffen School of Medicine, is named in TIME Magazine.
Additional coverage: LA Business Journal, Advisory Board
February 6, 2026
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma - Dr. Brian Shuch, the director of the Kidney Cancer Program, the Alvin & Carrie Meinhardt endowed chair in Kidney Cancer Research, and a member of the UCLA Health Jonsson Comprehensive Cancer Center, provides expert commentary to Urology Times.
January 26, 2026
Previously unknown bacterial component in kidney stone formation discovered - Dr. Kymora Scotland, assistant professor of Urology, director of Endourology Research, and associate director of Endourology Fellowship Program, provides expert commentary to Medical Xpress.
Additional coverage: MSN, Sci Tech Daily, Science Alert, KABC, KFI-AM, Science Alert
January 21, 2026
5 things doctors wish men knew about sexual health - Dr. Juan Andino, assistant clinical professor of urology at the David Geffen School of Medicine at UCLA, provides expert commentary to The New York Times.
January 7, 2026
Hit play & get moving: podcasts to power your 2026 fitness & health goals - Dr. Jesse Mills, director of the men's clinic at UCLA, fellowship director of the UCLA male reproductive medicine and surgery program, and director of UCLA Urology Santa Monica, provides expert commentary to WOR-AM.
Additional coverage: KTOM-FM & 545 others
January 5, 2026
Do all cancers need to be treated? Some doctors say no. - Dr. Leonard Marks, professor and deKernion endowed chair in urology and member of the UCLA Health Jonsson Comprehensive Cancer Center, provides expert commentary to Advisory Board.
January 4, 2026
Omega-6 fatty acid consumption - Dr. William Aronson, professor of urology at the David Geffen School of Medicine at UCLA and member of the UCLA Health Jonsson Comprehensive Cancer Center, provides expert commentary to WESA-FM.